Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Type I interferons play a key role in the development of various skin diseases.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Dutasteride makes alcohol less sedating and may lead to less drinking in men.

Hair restoration surgery has advanced, focusing on natural results and may improve further with new techniques and therapies.

Lipedematous scalp is mainly caused by an increase in fat tissue under the skin and is different from lipedematous alopecia.

Finasteride effectively treats male hair loss, improving growth and density.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Apremilast improved symptoms in patients with severe skin conditions.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Finasteride can cause serious emotional side effects; doctors should check patients' mental health history before prescribing.

Some new oral anticoagulants may also cause hair loss and might not be better than traditional ones for preventing hair loss.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Minoxidil helps stabilize hair loss, increase density, and reduce shedding after hair transplant surgery.

Nd:YAG laser can reduce hair with multiple treatments, but permanent removal isn't guaranteed.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Oral zinc sulphate reduces dark hair color in mice.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Some psychiatric medications can cause reversible hair loss.